Digital Health, Drug Development and Pharmaceuticals

Daewoong Pharmaceutical revolutionizes drug development with AI-Driven DAISY system

Digital Health Global

MARCH 28, 2024

Daewoong Pharmaceutical , a prominent player in the South Korean pharmaceutical industry, has unveiled its groundbreaking drug development system, Daewoong AI System (DAISY). About DAISY DAISY represents the culmination of over 40 years of research and development by Daewoong Pharmaceutical.

Drug Development

Drug Development Pharmaceuticals Digital Health

Biofourmis announces major agreements with top pharmaceutical companies

Digital Health Global

FEBRUARY 19, 2024

Biofourmis , a global digital health and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms. Beyond digital biomarker and endpoint expertise, pharmaceutical partners are leveraging Biofourmis to streamline study timelines through its Digital Clinical Trials solution.

Pharmaceuticals

Pharmaceuticals Leadership Drug Development Digital Health

The next revolution in the pharmaceutical industry: the transformative potential of AI

Digital Health Global

SEPTEMBER 19, 2023

The pharmaceutical landscape is undergoing a momentous transformation, marked by the convergence of cutting-edge technologies that are redefining every aspect of the industry. The first application of AI to the pharmaceutical industry is its use in ramping up and improving new drug discovery.

Pharmaceuticals

Pharmaceuticals Drug Development Digital Health

Debiopharm and ThinkingNodeLife.ai Forge a Strategic Partnership to Propel Cancer Drug Development with AI Digital Cell Clones

Digital Health Global

JANUARY 10, 2024

LAUSANNE, Switzerland & SAN DIEGO–(BUSINESS WIRE)–Debiopharm, an independent biopharmaceutical company headquartered in Switzerland, and ThinkingNodeLife.ai (TNL), a trailblazer in AI Digital Cells Lab in USA, are pleased to announce a collaborative partnership aimed at advancing the development of a cutting-edge cancer drug.

Drug Development

Drug Development Pharmaceuticals Digital Health

Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson’s Disease

Digital Health Global

MARCH 26, 2024

BASEL, Switzerland–(BUSINESS WIRE)–Indivi, a leading MedTech company headquartered in Basel, Switzerland, has entered into an agreement with Biogen to advance digital health technology and develop digital biomarkers for Parkinson’s disease.

Health Technology

Health Technology Digital Health BioTech Drug Development

MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment

Digital Health Global

JANUARY 9, 2024

The investment adds to a growing list of prominent digital health investors in Europe and the United States, including Nina Capital and Young Sohn, a co-founder of Veeva Systems. The funding speaks to the global nature of pre-approval access and its increasing importance in the drug development process. “

Pharmaceuticals

Pharmaceuticals Drug Development Digital Health Health Technology

Drug Discovery and Early Development Outsourcing Services Industry Analysis – M&As, Partnerships and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion – ResearchAndMarkets.com

Digital Health Global

APRIL 5, 2024

DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities in Drug Discovery and Early Development Outsourcing Services” report has been added to ResearchAndMarkets.com’s offering. hike over 2022, with more than 6,100 molecules in active development.

Drug Development

Drug Development Pharmaceuticals Digital Health Health Technology

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response

Digital Health Global

MARCH 29, 2023

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We

Drug Development

Drug Development Pharmaceuticals Life Science Digital Health

Massive Bio Pioneers Clinical Trial Recruitment Innovation with Strategic Support from Evernorth Health, Inc.

Digital Health Global

OCTOBER 3, 2023

a trailblazing entity in the realm of digital health technology, proudly announces a pivotal advancement in clinical trial recruitment, fortified by a strategic relationship with Evernorth Health, Inc (ENI).

Drug Development

Drug Development Digital Health Pharmaceuticals Health Technology

Debiopharm Innovation Fund Launches New Seed Funding Activity to Accelerate Digital Transformation of Cancer Care and Pharma R&D

Digital Health Global

SEPTEMBER 28, 2023

The new seed funding activity will therefore pave the way for the next generation of treatments and digital health, providing healthcare professionals with better tools to improve experiences and outcomes for patients. Since 2017 Debiopharm has invested in 15 AI and digital health companies, typically leading the investment rounds.

Drug Development

Drug Development Pharmaceuticals Digital Health Life Science

How to Leverage DTx with Your Digital Health Strategy | Part 1 of 2

Xealth

JUNE 27, 2023

David Slifka, Vice President, Commercial Enablement The digital health ecosystem is a complex place. Confusion abounds among healthcare providers regarding digital therapeutics (DTx) terminology and classifications, and understandably so. DTx fall within the digital medicine subset within the larger digital health ecosystem.

Digital Health

Digital Health Drug Development Pharmaceuticals EHR

Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial

Digital Health Global

APRIL 16, 2024

The Phase IV trial, funded by a top-10 global pharmaceutical company, had a narrow recruitment window to enroll patients suffering from Anemia in End Stage Kidney Disease (ESKD) across more than 40 dialysis centers, involving 476 site users. .–(BUSINESS WIRE)– Medable Inc. , Renal Care ’s (USRC) investigator-initiated trial.

Drug Development

Drug Development Pharmaceuticals Health science Digital Health

QuantHealth Announces $15M Series A for its AI Platform That Enhances Success of Clinical Trials

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. This decline is happening at a time when the need for efficient drug development has never been greater. This happens because there are major gaps in the research needed to support clinical trials.

BioTech

BioTech Drug Development Life Science Pharmaceuticals

Medable’s New Intelligent Automation Capabilities Cut Clinical Trial Technology Deployment Timelines By 50%

Digital Health Global

JANUARY 8, 2024

Top-10 global pharmaceutical companies are already benefiting from Medable’s novel technology, shaving weeks off build times. Its digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure.

Life Science

Life Science Drug Development Pharmaceuticals HIPAA

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

Lloyd Price

DECEMBER 11, 2023

The WHO and the India G20 presidency emphasised its importance by launching ‘The Global Initiative of Digital Health’ (GIDH) in August, proclaiming: “Digital health is a proven accelerator to advance health outcomes and achieve Universal Health Coverage and health-related Sustainable Development Goals.”

Pharmaceuticals

Pharmaceuticals Digital Health Drug Development Life Science

6 challenges healthtech can help us tackle – Pt.2

Digital Health Global

NOVEMBER 2, 2023

Wearable monitoring devices, genomics, and AI play vital roles in this transformation, enabling personalized interventions and collective health data sharing for research. Drug development The traditional drug discovery process is characterized by its protracted timeline, high costs, and significant attrition rates among drug candidates.

Drug Development

Drug Development Pharmaceuticals Public Health Telehealth

Medtech: BrainTale Gathers €4.5 Million to Accelerate the Development of Its Solution for Diagnosis, Monitoring and Prediction of Neurological Disorders

Digital Health Global

JUNE 20, 2023

million from Capital Grand Est and MACSF, as well as business angels, to accelerate its development in Europe and the United States. STRASBOURG, France–(BUSINESS WIRE)– BrainTale, a French medtech deciphering white matter to enable better brain care, announces it has gathered € 4.5 Today, the company has gathered €4.5

Life Science

Life Science Drug Development BioTech Pharmaceuticals

Accelerator Life Science Partners Launches Biotechnology Startup Company in Singapore with $16M in Series A Commitments

Digital Health Global

SEPTEMBER 27, 2023

About Automera Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. About ClavystBio ClavystBio’s mission is to accelerate the commercialization of life science breakthroughs into health impact.

Life Science

Life Science Drug Development HC BioTech

COVID-19 has accelerated adoption of non-contact patient monitoring technology, says Frost & Sullivan analysis

Healthcare IT News - Telehealth

MAY 29, 2020

“These technologies can also be leveraged by pharmaceutical companies to monitor the results of the drugs developed by them," said Ashish Kaul, technical insights senior research analyst at Frost & Sullivan. THE LARGER CONTEXT. She cites examples such as Binah.ai

Mental health

Mental health Drug Development Pharmaceuticals Telehealth

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

FEBRUARY 18, 2024

Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pharmaceuticals

Pharmaceuticals healthcare technology Digital Health Leadership

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

NOVEMBER 21, 2023

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Email lloyd@nelsonadvisors.co.uk Subscribe Today! Buy, build or partner?

Drug Development

Drug Development Health science healthcare technology Leadership

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Lloyd Price

FEBRUARY 18, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! Subscribe Today!

Pharmaceuticals

Pharmaceuticals healthcare technology Leadership Drug Development

Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases

Digital Health Global

MARCH 16, 2023

About Wellington Partners Wellington Partners is a leading European venture capital firm investing in the most promising early- and growth stage life science companies in the fields of biotechnology, therapeutics, medical technology, diagnostics and digital health. With funds totaling more than €1.2 Forbion manages well over EUR 2.3

Life Science

Life Science Pharmaceuticals BioTech Drug Development

#091: Francesca Wuttke on Digital Transformation, Startups and Corporate Relationships

Digital Health Today

SEPTEMBER 6, 2019

Our guest is Francesca Wuttke, PhD, the Chief Digital Officer of Almirall. Almirall is an international pharmaceutical company founded in 1943 and based in Barcelona – which is where Francesca is based. Francesca is responsible for developing and executing an end-to-end company-wide digital transformation.

Digital Health

Digital Health Drug Development Pharmaceuticals

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years.

BioTech

BioTech Life Science Drug Development Patient Experience

Machine Learning and Computational Algorithms are revolutionising Diagnostics and attracting significant HealthTech M&A interest

Lloyd Price

APRIL 22, 2024

HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Pharma giants acquiring AI drug discovery firms: Pharmaceutical companies are increasingly looking to AI to streamline drug development, leading to potential acquisitions. Subscribe Today!

healthcare technology

healthcare technology Leadership Drug Development Digital Health

Digital Therapeutics: the keys to succeed!

Digital Health Today

AUGUST 7, 2019

Digital Therapeutics (DTx) have been under the spotlight this past year. They have the potential to become a game changer in healthcare for patients, healthcare professionals, pharmaceuticals and insurance companies. The Digital Therapeutics Alliance developed a definition to differentiate DTx solutions from health and wellness apps.

Pharmaceuticals

Pharmaceuticals Digital Health Drug Development Primary Care

Turbine Upsizes its Series A Round to €25.5 Million and Appoints Seasoned Independent Directors to its Board

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Lars Staal Wegner, M.D.

BioTech

BioTech Life Science Leadership Drug Development

A guide to connected health device and remote patient monitoring vendors

Healthcare IT News - Telehealth

MAY 6, 2020

Bardy Diagnostics is a digital health and remote patient monitoring company focused on addressing a long-standing complaint by cardiac electrophysiologists and cardiologists regarding their frequent inability to clearly distinguish the P-wave on ECG strips of existing monitors. And the list will continue to be updated over time.

Connected Health

Connected Health Telehealth Pharmaceuticals EHR

Connected Health Pulse

Daewoong Pharmaceutical revolutionizes drug development with AI-Driven DAISY system

Biofourmis announces major agreements with top pharmaceutical companies

Trending Sources

The next revolution in the pharmaceutical industry: the transformative potential of AI

Debiopharm and ThinkingNodeLife.ai Forge a Strategic Partnership to Propel Cancer Drug Development with AI Digital Cell Clones

Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson’s Disease

MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment

Drug Discovery and Early Development Outsourcing Services Industry Analysis – M&As, Partnerships and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion – ResearchAndMarkets.com

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response

Massive Bio Pioneers Clinical Trial Recruitment Innovation with Strategic Support from Evernorth Health, Inc.

Debiopharm Innovation Fund Launches New Seed Funding Activity to Accelerate Digital Transformation of Cancer Care and Pharma R&D

How to Leverage DTx with Your Digital Health Strategy | Part 1 of 2

Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial

QuantHealth Announces $15M Series A for its AI Platform That Enhances Success of Clinical Trials

Medable’s New Intelligent Automation Capabilities Cut Clinical Trial Technology Deployment Timelines By 50%

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

6 challenges healthtech can help us tackle – Pt.2

Medtech: BrainTale Gathers €4.5 Million to Accelerate the Development of Its Solution for Diagnosis, Monitoring and Prediction of Neurological Disorders

Accelerator Life Science Partners Launches Biotechnology Startup Company in Singapore with $16M in Series A Commitments

COVID-19 has accelerated adoption of non-contact patient monitoring technology, says Frost & Sullivan analysis

Where are HealthTech's soft landing M&A deals in today's market?

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases

#091: Francesca Wuttke on Digital Transformation, Startups and Corporate Relationships

Let’s Save the Date and Make Patient Engagement Official in 2022

Machine Learning and Computational Algorithms are revolutionising Diagnostics and attracting significant HealthTech M&A interest

Digital Therapeutics: the keys to succeed!

Turbine Upsizes its Series A Round to €25.5 Million and Appoints Seasoned Independent Directors to its Board

A guide to connected health device and remote patient monitoring vendors

Stay Connected